Home Healthcare Animal Health Veterinary Infectious Disease Diagnostics Market

Veterinary Infectious Disease Diagnostics Market Size, Share & Trends Analysis Report By Product (Immunodiagnostics, Molecular Diagnostics, Others), By Applications (Dogs, Cats, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Dhanashri Chandgude | Format:

Veterinary Infectious Disease Diagnostics Market Size

The global veterinary infectious disease diagnostics market size was valued at USD 2.46 billion in 2025 and is projected to grow from USD 2.67 billion in 2026 to USD 5.12 billion by 2034, registering a CAGR of 8.49% during the forecast period from 2026 to 2034. North America dominated the veterinary infectious disease diagnostics market with a market share of 38.4% in 2025.

Veterinary infectious disease diagnostics refers to tests that help determine and identify various animal illnesses. Various techniques are used to administer these treatments while utilizing patient tissue, excrement, and blood samples. New methods and technology developed for human diagnostics are frequently employed in veterinary diagnostics. Molecular diagnostics (PCR testing, microarrays, etc.), immunodiagnostics (lateral flow assays, ELISA, etc.), and other methods are used in veterinary diagnostics. According to market size, animal infectious diseases are the most common illness. An optimistic view of animal diagnosis encourages the number of species to grow. The market for veterinary infectious disease diagnostics is growing as more companion animals contract various infectious diseases, pet insurance demand is increasing, and there are more companion animals and more modern diagnostic tools for animals.

Market Key Takeaways

Global Market Size & Growth

Immunodiagnostics dominate the product segment.
Dogs dominate the application segment.
North America is the highest shareholder in the global market.
Veterinary Infectious Disease Diagnostics Market Size

Download a Free Sample To learn more about this report.

Segmentation Analysis

By Product

The global market is bifurcated into immunodiagnostics, molecular diagnostics, and others. The immunodiagnostics segment dominates the global market and is predicted to exhibit a CAGR of 9.21% over the forecast period. Antibodies' capacity to bind to a particular antigen of interest is used in immunodiagnostics, which are products. Diagnostics of this type are used to detect and diagnose infectious diseases in animals. Numerous in vitro diagnostic tests are also commercially available. These techniques are employed in the immunodiagnostic identification of antibodies for infectious illnesses in animal specimens. Furthermore, it is necessary to find antigens or antibodies directed against invaders like viruses, bacteria, or parasites to diagnose animal infectious disorders. Several immunodiagnostic techniques, like lateral flow assays and ELISA, are also used to find animal infectious disorders.

In addition to that, the techniques behind these examinations differ. For instance, the presence of a control line in lateral flow assays demonstrates that the test is effective. A target line or lines are included in the test, and one or more test lines are intended to include spontaneous user protocols. These tests also require little preparation because they can be seen visually.

Veterinary Infectious Disease Diagnostics Market Size By Segments

Request Customizationto receive a tailored report.

By Application

The global market is bifurcated into dogs, cats, and others. The dog segment owns the highest market share and is predicted to exhibit a CAGR of 9.0% over the forecast period. Dogs typically rank highly among the most well-liked pets in the world. This is mainly because dogs are social animals and require less maintenance than other pets. American Pet Products Association, Inc. figures show that approximately 90 million dogs are kept as pets in the United States. In addition, increased public understanding of the importance of routine preventative veterinarian care and an increase in the average lifespan of companion animals have been directly correlated during the past few decades. Regardless of the serious condition, a quick diagnosis and treatment are required if a dog acquires an infection.

Examples of infectious diseases that are spreadable and have the potential to harm dogs and demand prompt medical attention include canine distemper, canine coronavirus, and canine influenza. Hepatitis, ringworm, and parvovirus are other contagious illnesses that can harm dogs. As a result, there has been an increase in the need for veterinary disease diagnostics, which has helped to drive the market's growth.

Veterinary Infectious Disease Diagnostics Market Share By Segments

Speak to an Analystto discuss market opportunities.

Regional Analysis

North America: Dominant Region with 9.41% of the Market Share

North America is the most significant global veterinary infectious disease diagnostics market shareholder and is estimated to exhibit a CAGR of 9.41% over the forecast period. The global veterinary infectious disease diagnostics market is fragmented, with North America accounting for most sales. This can be attributed to several factors, including how simple it is to diagnose veterinary infectious diseases. The sector is also growing due to an increase in the number of individuals in the area who own pets and a corresponding rise in awareness of companion animal health. Due to the increased public awareness of the importance of early detection of diseases in companion animals, the region holds the largest market share. Additionally, a surge in customer demand for better veterinary treatment alternatives is projected to fuel the market's growth. The increasing prevalence of numerous animal-related diseases is another significant factor supporting this market's expansion.

North America Veterinary Infectious Disease Diagnostics Market Revenue Share 2025

Unlock Regional Insightsto access country-level data, & regional trends.

Asia-Pacific: Fastest Growing Region with the Highest Cagr

Asia-Pacific is anticipated to exhibit a CAGR of 13.94% over the forecast period. The veterinary infectious disease diagnostics market has enormous potential in Asia-Pacific, which is predicted to grow at the fastest rate over the projected period. This is primarily due to an increase in the proportion of households with pets. As they are still developing, the nations of the Asia-Pacific area are regarded as emerging markets. Both China and Australia are exhibiting evidence of a rise in the number of pet owners and a rise in understanding about the early diagnosis and treatment of illnesses common in companion animals. In addition, the cost of veterinary care for animals in the area is rising, which has increased the demand for veterinary infectious disease diagnostics.

In Europe, the market for these products is growing significantly due to increased R&D efforts for veterinary infectious disease diagnostics. Another important factor driving the expansion of the veterinary infectious disease diagnostics market in this region is the rise in the prevalence of infectious disorders among companion animals. Additionally, the industry is growing because of increased awareness about the health of companion animals. The accessibility of veterinary infectious disease diagnostics services also facilitates the market's expansion.

LAMEA is a developing market since spending on animal healthcare is expected to increase during the projected period, opening up lucrative prospects for industry participants. Due to economic reforms that have raised living conditions in this region over the past 20 years and opened up various opportunities for the animal research and healthcare industries, this area has had the fastest economic growth. These factors are projected to expand the market for veterinary infectious disease diagnostics.

List of Key and Emerging Players in Veterinary Infectious Disease Diagnostics Market

Biomerieux S.A.
Heska Corporation
IDEXX Laboratories Inc.
IDVet
Indical Bioscience
Neogen Corporation
Randox Laboratories Ltd.
Thermo Fisher Scientific Inc.
Virbac
Zoetis Inc.

Key Industry Developments

June 2026
IDEXX Laboratories launched an advanced molecular diagnostic test for rapid detection of infectious diseases in companion animals. The solution delivers faster and more accurate diagnosis, helping veterinarians initiate timely treatment.
April 2026
Zoetis expanded its Vetscan diagnostic portfolio with new infectious disease testing solutions for livestock and companion animals. The launch enhances point-of-care diagnostics and disease surveillance capabilities.
February 2026
Thermo Fisher Scientific introduced new veterinary PCR diagnostic kits for detecting multiple infectious pathogens in poultry and livestock. The products support disease control programs and improve laboratory testing efficiency.
October 2025
bioMérieux expanded its veterinary microbiology and infectious disease testing portfolio with enhanced molecular diagnostic solutions for animal health laboratories.

Report Scope

Segmentation

By Product 3
  • Immunodiagnostics
  • Molecular Diagnostics
  • Others
By Applications 3
  • Dogs
  • Cats
  • Others

Geographies Covered

North America 2
  • U.S.
  • Canada
Europe 8
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Nordic
  • Benelux
APAC 7
  • China
  • Korea
  • Japan
  • India
  • Australia
  • Taiwan
  • South East Asia
Middle East and Africa 6
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Egypt
  • Nigeria
LATAM 5
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
Competitive Coverage Biomerieux S.A. · Heska Corporation · IDEXX Laboratories Inc. · IDVet · Indical Bioscience
Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The veterinary infectious disease diagnostics market size is valued at USD 2.67 Billion in 2026 and is projected to reach USD 5.12 Billion by 2034, at a CAGR of 8.49% during the forecast period 2026-2034.
North America dominated the market with a share of 38.4% in 2025.
The leading players in this market are Biomerieux S.A., Heska Corporation, IDEXX Laboratories Inc., IDVet, Indical Bioscience.
The veterinary infectious disease diagnostics market is projected to grow at a CAGR of 8.49% during the forecast period of 2026 2034.
About the Author
Dhanashri Chandgude
Dhanashri Chandgude
Senior Research Associate

Dhanashri Chandgude is a healthcare research professional with over four years of experience in market intelligence, specializing in market analysis, secondary research, market estimation, and forecasting across the pharmaceutical, biopharmaceutical, and medical device sectors. She provides actionable insights into market dynamics, competitive intelligence, industry trends, and growth opportunities to support strategic business decision-making.

Her expertise includes assessing market size, growth potential, and revenue opportunities through structured market estimation and forecasting methodologies, including top-down, bottom-up, and epidemiology (EPI)-based approaches. She has hands-on experience analyzing disease epidemiology, treatment landscapes, market trends, competitive scenarios, and industry developments to develop robust market forecasts.

Report Details
−
Trusted by Industry Leaders
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Request Sample Order Report Now